AcelRx Pharmaceuticals has received a US patent which provides intellectual property protection for sufentanil NanoTab based products through late 2030. The patent entitled, Small-Volume Oral Transmucosal Dosage Forms, describes a method ...
Tags: US patent, clinical technology, pharmaceutical product
Accelrys, a scientific enterprise R&D software and services company, has purchased the web-based drug discovery information management technology, Hit Explorer Operating System (HEOS) from Scynexis. HEOS is a Software-as-a-Service (SaaS) ...
Tags: Accelrys, purchased, Hit Explorer Operating System, Scynexis, SaaS, drug